Introduction
Chronic obstructive pulmonary disease (COPD) refers to a progressive deterioration of lung function and a series of mental and physical comorbidities. 1 It is one of the main contributors to the global burden of disease. COPD has caused significant morbidity and mortality especially in developing countries. There are also excessive health resource consumption and health expenditures attributed to COPD worldwide. Researchers have found greater burden of COPD in China than in developed countries. In 2008, COPD was known as the fourth and third leading cause of death in urban and rural areas in China, respectively. 2 There is big variation in the reported prevalence of COPD among different geographic areas in China, which is partly due to different levels of exposure to risk factors and disparities in socioeconomic development among different areas. 3 Despite the abundant information on the epidemiological impact of COPD, there is limited evidence on its economic influence. 4 Hence, in-depth study on the disease burden of COPD is still an urgent need.
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The aim of this systematic review was to quantify the disease burden of COPD in China and to determine the risk factors of the disease. Data on prevalence, consultation rate, risk factors, mortality, disease burden, cost of illness, and quality of life (QoL) are extracted from available studies and analyzed to improve public awareness of COPD.
Methods
Literature search
A systematic review was conducted to identify articles regarding disease burden of COPD in mainland China in both Chinese and English published before October 2015. The literature search was carried out in electronic databases such as CNKI, Wanfang Data, VIP, PubMed, Embase, and Cochrane. The search terms were as follows: "COPD", "cost", and "health care costs". With CNKI and PubMed as examples, the retrieval strategies are shown in Box 1. Duplicate studies were identified and removed by using NoteExpress.
Study selection
Publications identified from the first round of search were reviewed by title and abstract independently by two investigators (BZ and YW). The inclusion and exclusion criteria used for study selection are listed in Table 1 .
Methodological quality assessment
The quality of the studies was assessed by using a selfestablished scale based on Agency for Healthcare Research and Quality Assessment Form, 5 the Newcastle-Ottawa Scale, 6 and Drummond Criteria 7 ( Table 2 ). The studies were assessed independently by two reviewers (BZ and JM). The assessment scores were then confirmed and pooled together. Quality score was in the range of 0-10 points, and the articles were categorized into three classes. Articles with $8 points were listed under category A, 4-7 points under category B, and ,4 points under category C. This study excluded studies with poor quality, that is, those in category C.
Data extraction
A standardized data extraction form was used to obtain data from research studies included in the final review, including article name, journal of publication, authors, institution of study, year of publication, study design, region of study, study duration, data source, sample characteristics (population and age), prevalence, incidence, influencing factors, consultation rate, mortality, disability-adjusted living years (DALY), years of life lost (YLL), years lost due to disability (YLD), QoL, the scale used for QoL assessment, direct medical cost (yuan per capita, per year), direct medical cost (per capita, per year) #% of income per year, direct non-medical cost (yuan per capita, per year), direct nonmedical cost (per capita, per year) #% of income per year, indirect cost (yuan per capita, per year), indirect cost (per capita, per year) #% of income per year, total disease cost Box 1 examples of retrieval strategy CNKI retrieval strategy #1 "Chronic Obstructive Lung" OR "Chronic Obstructive Pulmonary Disease" OR "COPD" #2 "disease burden" OR "epidemic" OR "prevalence" OR "mortality" OR "incidence" OR "hospitalization rate" OR "economic burden" OR "cost" OR "expense" OR "disability adjusted life years" OR "disability adjusted living years" OR "DALY" OR "years lost due to disability" OR "years of life lost" OR "YLD" OR "YLL" #3 #1 AND #2 
Results
Literature search
The process and results of literature screening are shown in Figure 1 . Of all the articles assessed by the quality assessment scale, six were recognized as low quality and excluded from the research (Table S1 ). 
Burden of disease Prevalence
A total number of 13 studies are engaged in quantitative analysis of prevalence ( Table 4 ). The overall prevalence of COPD in China ranges from 1.20% to 8.87%, with an average of 5.87%. The prevalence rate of COPD is significantly lower in research studies including population aged ,35 years, in consistent with the finding that the prevalence rate of COPD rises with the age of certain population segmentation. 44, 53 An overall trend is that the prevalence rate of COPD is higher among men (7.76%) in comparison with women (4.07%) and that the disease is more prevalent in rural areas (7.62%) than in urban areas (6.09%). 31 
Consultation rate
The diagnostic rate of COPD (number of patients diagnosed with COPD divided by the number of COPD cases found through epidemiology research) in China varies from 23.61% to 30.00%. 23, 37, 44 The percentage of COPD patients receiving outpatient treatment is around 50%, 50, 56 while the admission rate ranges between 8.78% and 35.60% 28, 50, 56 
(Figure 2).
A national survey across seven provinces 37 found that the regular medical treatment rate of COPD patients was only 7.9% which calls for the improvement of the prevention and management of COPD. There is still a large amount of unmet needs in health services among COPD patients in China.
Risk factors of COPD
A total of 13 studies analyzed the risk factors of COPD. Figure 3 shows the major factors and the number of studies that define them as risk factors of COPD in China. Tobacco exposure and biomass fuel/solid fuel usage are documented as two important risk factors of COPD, mentioned in Figure 2 Consultation rate of COPD in China. Note: *Diagnostic rate is defined by the number of patients who have been diagnosed with COPD in the past divided by the number of subjects recognized as COPD cases through epidemiology research. Other risk factors include cardiovascular disease, 11 lack of exercise and social support, 27 low level of household income, 33 frequency of cooking, 48 having house remodelling in the past 5 years, 48 and poor ventilation in the kitchen, 53 which are not listed in the figure because of their low level of evidence strength; that is, they are mentioned by only one study. Another case-control study 46 conducted in Xuanwei, a region with high exposure to indoor smoky coal emissions, tested the association between single-nucleotide polymorphisms and COPD risk and concluded that polymorphisms in CSF2, IL8, and PTEN may have an effect on the pathogenesis of COPD.
Mortality
According to the Global Burden of Disease Study 2010, 8 COPD ranked among the top three leading causes of death in China, causing 934,000 deaths (534,000 men and 400,000 women) in 2010.
The age-standardized mortality rate of COPD declined from 235.2/100,000 in 1990 to 90.5/100,000 in 2010. 8 Another regional study reported a similar trend:
18 the age-standardized mortality rate of COPD in Jinshan District, Shanghai (located in eastern China) declined from 219.43/100,000 in 1985 to 45 .66/100,000 in 2011, yet the level of premature mortality of COPD in China is still worse than the average outcomes of the member coutries of Group of Twenty (G20). 22 Another two studies reported the level of COPD mortality in Kunming, Yunnan Province which is located in the southwest of China: the age-standardized mortality rate of COPD in 2003 was the highest in rural areas (184.4/100,000), followed by suburban (129.5/100,000), and then urban areas (51.2/100,000), 55 while the crude mortality rate in rural Kunming was 65.67/100,000 in 2010. 24 Lin et al 9 suggested that ~65 million people may die from COPD from 2003 to 2033, accounting for 19% of all deaths over this period, unless the smoking rate and solid-fuel usage are controlled.
DALY
Combining premature mortality (YLL) and disability (YLD) together in terms of DALYs provides an overall picture of the disease burden of COPD in China. According to the Global Burden of Disease Study 2010, a total number of 16,723,800 DALYs were caused by COPD, ranking among the top 10. 22 The age-standardized rate of DALY declined from 4,120.1/100,000 in 1990 to 1,575.9/100,000 in 2010. 10 Another regional study reported that the rate of DALY in rural Kunming, Yunnan Province, was 602/100,000 (673/100,000 among men and 526/100,000 among women). 24 COPD also remained one of the leading causes of YLL, 10 causing 12,946,000 YLL. Age-standardized YLL rates of COPD decreased from 3,756.9/100,000 in 1990 to 1,235.6/100,000 in 2010, ranked 18 in 2010 among the member countries of G20, worse than the average outcome. In Kunming, Yunnan Province, COPD was ranked second among the causes of YLL in urban and suburban areas and ranked top in rural areas in 2003. 55 In Xuzhou, Jiangsu Province, COPD caused 1.76 years of potential life lost per patient among men and 1.18 among women in 2007. 27 In Shanghai Jinshan District, over 27 years, from 1985 to 2011, the standardized rate of years of potential life lost decreased from 1,543/100,000 to 140/100,000. 18 
Cost of illness Total disease cost
A total of 12 studies analyzed the disease cost ( Table 5 ). The direct cost of COPD ranges from 499 to 1,930 USD per capita per year. The direct medical cost of COPD ranges from 72 to 3,565 USD per capita per year, accounting for 33.33%-118.09% of local average annual income. 28, 47 The indirect cost ranges from 20 to 783 USD per capita per year, with the total disease cost being around 700-1,800 USD. The study conducted in Chengdu suggested that the direct cost of COPD accounted for 22.98% of patients' annual income, while indirect cost accounted for 4.72%. 17 A human capital approach is usually adopted in calculating the indirect cost, while there is disagreement concerning the loss of working time due to COPD. A study in rural Yunnan found that COPD patients were incapable of working for about 150 days each year, while their family members were unable to work for 59 days each year; 28 hence, the lifetime indirect cost of COPD was 3,414 USD per capita when the method of YPLL was applied. Two other research studies brought forth similar conclusions that COPD patients were prevented from work for an average time of 17 days 41 and 15 days per year, 29 indicating high economic impact of COPD caused by loss in productivity.
In terms of lifetime indirect loss due to COPD, a multinational evaluation claimed the average losses in China to be the lowest (678 USD 32 ) among five countries. Another research conducted in Guangzhou concluded that the lifetime loss was 7,256 USD per capita. 34 Only one study reported the intangible cost of COPD: 1,168 USD per capita per year in rural Yunnan. 24 
Outpatient and inpatient expenditure
The results of hospitalization costs of COPD vary largely among different studies. Hospital-based studies usually lead to higher hospitalization expenses, as shown in Table 6 . Nonetheless, researchers consistently report that inpatient services account for a larger proportion of total disease 
Main reason for cost
In terms of the influence factors of cost, the most frequently mentioned factors are number of visits/admissions 13, 17, 47, 49, 56 and severity of the disease. 13, 39, 49, 56 Researchers found that patients with high-income levels usually generate higher medical costs and that those unemployed often bear lower economic burden. In terms of insurance type, patients with free medical services (a type of insurance for public servants where most of their medical expenditures are paid by the state) usually have higher medical costs. 56 Yet contradictory perspectives on the influence of patient sources on medical costs exist. Some believe that local patients bear higher medical costs because of the relatively higher income level and sound insurance system, 13 while others hold the opposite view that patients from nonlocal areas have undergone heavier economic burden due to the severity of their diseases when they need to go to a major city for treatment. 34 Other influencing factors include length of stay, 13, 34 age, 40, 47 status of smoking, 47 whether undertaking surgery, 34 marital state, 34 attitude toward the disease, 49 and physical exercise. 17 
QoL
A total of 13 studies are included in the analysis of scales used for QoL assessment (Figure 4) . The most commonly used scales include Saint George Respiratory Questionnaire, 20, 21, 27, 36, 41 Airways Questionnaire 20 (AQ20), 14, 25, 30 12-item short-form health survey questionnaire, 38 Medical Coping Modes Questionnaire, 25 COPD Assessment Test, 26 EuroQol FiveDimensional Questionnaire, 32 and their revised versions. One of the studies established a self-made scale to assess the QoL of COPD patients. 54 An overall conclusion is that the quality assessment scores are lower among COPD patients, and four studies report significant results when compared with non-COPD patients. In two studies applying AQ20, the QoL of 56.1%-61.9% of COPD patients are in the lower and poorer level. Another two studies reported higher likelihood of COPD patients to have depression. 14, 26 The status of QoL is worse among COPD patients than in non-COPD patients, and they are at higher risk of having depression.
Conclusion
The prevalence of COPD shows a wide range of variation throughout the nation. An overall trend is that the prevalence rate is higher among men and in rural areas. The diagnostic rate, outpatient treatment rate, and admission rate of COPD are relatively low, indicating considerable under-treatment and unmet medical needs of COPD in China. Tobacco exposure and biomass fuel/solid fuel usage are documented as two important risk factors of COPD. The results of economic burden of COPD vary largely due to differences in study designs and heterogeneity of sample characteristics. While various studies reported different degrees of productivity loss in both COPD patients and their relatives, there is still an urgent need to understand the overall cost of COPD in China through well-designed research on disease burden. In view of the high smoking rate and considerable concerns related to air pollution and smog in China, as well as the large gap of unmet medical needs, countermeasures need to be taken to improve disease prevention and management to reduce disease burdens raised by COPD.
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